Evidence map›Paper›PMID 19230927›Full record

ReviewThe Journal of urology2009

Genetics and phenotyping of urological chronic pelvic pain syndrome.

Jordan Dimitrakov, David Guthrie

Abstract readReview
In one paragraph

Review in The Journal of urology, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed.

  1. Trial
  2. Article
  3. Review
  4. Chronic Prostatitis and Pelvic Pain Syndrome: Another Autoimmune Disease?Archivum immunologiae et therapiae experimentalis · 2021
    Review
  5. Article
  6. Acyloxyacyl hydrolase modulates pelvic pain severity.American journal of physiology. Regulatory, integrative and comparative physiology · 2018
    Article
  7. Visceral and somatic pain modalities reveal NaThe Journal of physiology · 2017
    Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. A watershed year for interstitial cystitis.The Journal of urology · 2010
    Article
  15. Review
  16. Review
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Jordan DimitrakovGeorge O'Brien Center for Urological Diseases Research, Harvard Medical School and Children's Hospital Boston, Boston, Massachusetts, USA.
David Guthrie

Funding

Genetic Studies of Interstitial CystitisR01DK081647 · NIDDK · BOSTON CHILDREN'S HOSPITAL · PI DIMITRAKOFF, JORDAN D, KUNKEL, LOUIS M · 2008 to 2011
$2.3M
Diagnostic Challenges in IC (and Male CPPS)R01DK065990 · NIDDK · QUEEN'S UNIVERSITY AT KINGSTON · PI DIMITRAKOFF, JORDAN D · 2003 to 2007
$976k
LINKAGE ANALYSIS IN INTERSTITIAL CYSTITISR21DK070672 · NIDDK · BOSTON CHILDREN'S HOSPITAL · PI DIMITRAKOFF, JORDAN D · 2006 to 2007
$492k
NIDDK NIH HHS R01 DK065990NIDDK NIH HHS R01 DK081647NIDDK NIH HHS R21 DK070672
6 · The paper itself

Abstract

purposeInterstitial cystitis/painful bladder syndrome and chronic prostatitis/chronic pelvic pain syndrome, collectively renamed urological chronic pelvic pain syndromes, are a group of medically unexplained physical symptoms. Diagnosis depends on excluding all possible causes of pain and treatment targets symptoms alone. An emerging body of research implicates systemic factors in the pathogenesis of urological chronic pelvic pain syndromes including abnormal sympathetic nervous system and hypothalamic-pituitary-adrenal axis activity. Several new lines of evidence also suggest a genetic component to disease pathogenesis. Despite ongoing efforts, neither effective treatments nor mechanistic understanding of the pathogenesis of urological chronic pelvic pain syndromes exists. MATERIALS AND

methodsWe performed a survey of the available literature on urological chronic pelvic pain syndromes. We reviewed recent research implicating genetic mechanisms in the development of urological chronic pelvic pain syndromes to find a systematic approach of rigorous phenotyping on which to base further investigation of these chronic pain conditions.

resultsThree studies revealed identifying genetic risk factors for disease. In addition, increasing lines of evidence of familial clustering and twin studies suggested a genetic basis for disease.

conclusionsGiven the success of genome-wide association studies in quantifying genetic risk in several polygenic diseases, we suggest a similar genome-wide approach to the study of urological chronic pelvic pain syndromes. As genome-wide association studies depend on carefully defined patient populations, we provide an outline for a thorough and multidisciplinary characterization of patient phenotypes. Although urological chronic pelvic pain syndromes continue to mystify clinicians and researchers alike, we believe the powerful new methods of unbiased interrogation of the whole genome based on systematically grouped patients possess enormous potential for progress in treating and understanding this disease.

Indexed as

HumansMalePhenotypeProstatitis

Identifiers

PMID19230927
PMCPMC2692547

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.